CeMines Inc. Licenses Lung Cancer IP to Ortho-Clinical Diagnostics
12/9/2008 11:36:30 AM
More...
|
CeMines Inc. Granted European Union Regulatory Clearance And CE Mark Registration Of Its CellCorrect LAb(R) Clinical Dx Test For Lung Cancer
1/11/2006 12:56:20 PM
More...
|
CeMines Inc. Announces Intent To Sell Its Research Tools Business, Including Multi-Million-Dollar Inventory Of Polyclonal Antibodies, cDNA And mRNA
12/13/2005 1:31:19 PM
More...
|
CeMines Inc. Receives Multiple USPTO Patent-Issue Notifications
11/30/2005 2:19:51 PM
More...
|
CeMines Inc. Appoints Gary C. Carter As Vice President Of Corporate Development
10/19/2005 5:13:12 PM
More...
|
CeMines Inc. Presented With "Innovative Technology Award" For 2004 By Jefferson Economic Council
10/19/2005 5:13:10 PM
More...
|
CeMines Estonia OU Files CE Mark Registration Seeking Clearance To Distribute Cell Correct LAb(TM)
10/19/2005 5:12:55 PM
More...
|
CeMines Inc. Selected To Present At American Association for Cancer Research
10/19/2005 5:12:50 PM
More...
|
CeMines Inc. And Children's Hospital-Denver Unite In Advanced Cancer Research Involving Validation Of Childhood Leukemia Biomarkers
10/19/2005 5:12:34 PM
More...
|
CeMines Inc. To Present At Medtech Insight's "Investment In Innovation" Conference
10/19/2005 5:12:32 PM
More...
|
|